Profitelligence Profitelligence · Filing Ledger Open RVTY research →

Form 8-K · Current Report · Filed 2025-10-24

Revvity Appoints New Chief Accounting Officer

On October 23, 2025, Revvity, Inc. appointed Anita Gonzales as its new Vice President and Chief Accounting Officer, effective immediately. Gonzales, previously the Company's Vice President and Controller, has over 25 years of experience in accounting and auditing, including roles at General Electric and PricewaterhouseCoopers.

Filer
Revvity Inc. RVTY · NYSE
Filed
Accession
0001193125-25-249958
CIK
0000031791
Signal
Medium impactHealthcare

Items reported

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

New CAO Appointed

Market reaction

Close before filing

$97.57

Next session

-0.4%

Since filing

+50.4%

Latest close

$146.73

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from RVTY reporting the same item, with the next session's move:

Revvity Announces Board Member Departure and New Appointments+1.3%

About Revvity Inc.

Revvity Inc. is a health science tools and diagnostics company that provides end-to-end solutions for research, development, testing, and clinical use. The company operates through two main segments: Life Sciences and Diagnostics, serving customers across pharmaceutical and biotechnology companies, diagnostic laboratories, academic institutions, and government organizations. Its portfolio includes reagents, consumables, assays, instruments, software, and specialized services that support workflows from discovery through diagnosis. Revvity focuses on areas such as translational multi-omics, biomarker identification, imaging, screening, detection, informatics, reproductive health, immunodiagnostics, and genomic testing. It also supports applications in rare disease testing, newborn screening, hereditary cancer, and broader clinical laboratory services. Based in Waltham, Massachusetts, Revvity plays an important role in the healthcare and life sciences ecosystem by helping researchers, clinicians, and laboratories generate and analyze data across a wide range of scientific and diagnostic applications.

Exchange NYSE Industry Diagnostics & Research Company website ↗

Never miss another RVTY filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts